PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsTrimethoprim
Trimethoprim
/ Trimethoprim, Bactrim, Primsol, Septra, Sulfatrim, Trimethoprim (trimethoprim) is a small molecule pharmaceutical. Trimethoprim was first approved as Septra on 1982-01-01. It is used to treat aids-related opportunistic infections, bacterial eye infections, bacterial infections, bronchitis, and escherichia coli infections amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
respiratory tract diseasesD012140
eye diseasesD005128
urogenital diseasesD000091642
immune system diseasesD007154
Trade Name
FDA
EMA
Trimethoprim (discontinued: Primsol, Proloprim, Trimethoprim, Trimpex)
Combinations
Bactrim, Septra, Sulfamethoxazole trimethoprim, Sulfatrim, Trimethoprim polymyxin b (discontinued: Bactrim, Cotrim, Cotrim d.s, Polytrim, Septra, Septra grape, Sulfamethoxazole trimethoprim, Sulfamethoxazole trimethoprim phenazopyridine, Sulfatrim, Sulfatrim-ss, Trimeth/sulfa, Uroplus, Uroplus ss)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sulfamethoxazole
+
Trimethoprim
Tradename
Company
Number
Date
Products
SEPTRAMonarch PharmaceuticalsN-017376 RX1982-01-01
1 products
SEPTRA DSMonarch PharmaceuticalsN-017376 RX1982-01-01
1 products
SULFATRIM PEDIATRICPAI PharmaN-018615 RX1983-01-07
1 products
BACTRIMSun Pharmaceutical IndustriesN-017377 RX1982-01-01
1 products, RLD
BACTRIM DSSun Pharmaceutical IndustriesN-017377 RX1982-01-01
1 products, RLD, RS
Show 14 discontinued
Trimethoprim
Tradename
Company
Number
Date
Products
TRIMETHOPRIMDr Reddys LaboratoriesN-018679 RX1982-07-30
1 products, RLD, RS
Show 3 discontinued
Polymyxin b sulfate
+
Trimethoprim sulfate
Tradename
Company
Number
Date
Products
POLYTRIMAllerganN-050567 DISCN1988-10-20
1 products, RLD
Hide discontinued
Phenazopyridine hydrochloride
+
Sulfamethoxazole
+
Trimethoprim
Tradename
Company
Number
Date
Products
SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDEAble LaboratoriesN-021105 DISCN2001-06-26
1 products
Hide discontinued
Trimethoprim hydrochloride
Tradename
Company
Number
Date
Products
PRIMSOLAllegis PharmaceuticalsN-074374 DISCN1995-06-23
1 products
PRIMSOLAllegis PharmaceuticalsN-074973 DISCN2000-01-24
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
bactrim bactrim dsNew Drug Application2024-12-30
bactrim dsNew Drug Application2024-07-25
polymyxin b sulfate and trimethoprimANDA2025-02-25
polymyxin b sulfate and trimethoprim sulfateNDA authorized generic2024-08-15
ss-tmpflOTC monograph not final2020-03-08
sulfamethox-tmp dsANDA2022-10-09
sulfamethoxazole and trimethoprimANDA2025-03-26
sulfamethoxazole and trimethoprim dsANDA2010-04-28
sulfamethoxazole, and trimethoprimANDA2009-10-09
sulfatrimNew Drug Application2025-03-06
Show 2 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
mycoses—D009181B35-B49
toxoplasmosisEFO_0007517D014123B58
urinary tract infectionsEFO_0003103D014552N39.0
chronic bronchitis—D029481J42
otitis mediaEFO_0004992D010033H66.9
bacterial infections—D001424A49
enterobacteriaceae infectionsEFO_1001313D004756—
escherichia coli infectionsEFO_1001318D004927B96.20
bronchitis—D001991J40
bacterial eye infections—D015818—
Show 20 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01E: Sulfonamides and trimethoprim antibacterials for systemic use
— J01EA: Trimethoprim and derivatives, systemic antibacterials
— J01EA01: Trimethoprim
— J01EE: Combinations of sulfonamides and trimethoprim, incl. derivatives
— J01EE01: Sulfamethoxazole and trimethoprim
— J01EE02: Sulfadiazine and trimethoprim
— J01EE03: Sulfametrole and trimethoprim
— J01EE04: Sulfamoxole and trimethoprim
— J01EE05: Sulfadimidine and trimethoprim
— J01EE07: Sulfamerazine and trimethoprim
— J01R: Combinations of antibacterials
— J01RA: Combinations of antibacterials
— J01RA02: Sulfonamides, combinations with other antibacterials (excl. trimethoprim)
— J04: Antimycobacterials
— J04A: Drugs for treatment of tuberculosis
— J04AM: Combinations of drugs for treatment of tuberculosis
— J04AM08: Isoniazid, sulfamethoxazole, trimethoprim and pyridoxine
HCPCS
Code
Description
S0039
Injection, sulfamethoxazole and trimethoprim, 10 ml
Clinical
Clinical Trials
290 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Lacrimal duct obstructionD007767——1————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTrimethoprim
INNtrimethoprim
Description
Trimethoprim is an aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge. It has a role as an EC 1.5.1.3 (dihydrofolate reductase) inhibitor, a xenobiotic, an environmental contaminant, a drug allergen, an antibacterial drug and a diuretic. It is a member of methoxybenzenes and an aminopyrimidine.
Classification
Small molecule
Drug classantibacterials (trimethoprim type), dihydrofolate reductase (DHFR) inhibitors
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC
Identifiers
PDB—
CAS-ID738-70-5
RxCUI—
ChEMBL IDCHEMBL22
ChEBI ID45924
PubChem CID5578
DrugBankDB00440
UNII IDAN164J8Y0X (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Trimethoprim
+
Polymyxin b
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Trimethoprim
+
Sulfamethoxazole
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Trimethoprim
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 84,549 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
47,452 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use